Reports
Reports
Sale
The global active pharmaceutical ingredient market size was valued at USD 205.9 billion in 2022, driven by the increasing prevalence of diseases across the globe. The market size is anticipated to grow at a CAGR of 5.5% during the forecast period of 2023-2031 to achieve a value of USD 333.4 billion by 2031.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Asia Pacific is among the leading regions for the global market, and with the growing awareness about the importance of a better lifestyle, people are starting to adopt and use health supplements daily. The increased consumption of bone and joint health supplements, especially among the ageing population in countries like India, China, and Japan, which have high population densities, will aid the market growth in the coming years. The middle-aged and elderly population are more inclined to go for preventive measures to avoid diseases and to support this notion. Companies are launching new and more organic products frequently with the customers' well-being in mind and increasing the general awareness among the people. Athletes, especially, include dietary supplements in their meals to achieve a complete nutritional balance, which is anticipated to further promote the growth of the region's bone and joint health ingredients market.
Bone and joint health ingredients generally refer to organic and natural extracts from a plant or animal-based source. They are high in nutrient value and are mainly used as dietary supplements to fulfil the need of the lacking nutrients. Some of the most known ones include Omega-3, Calcium, and Vitamin D.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Different forms of bone and joint health ingredients in the market include:
The types of bone and joint health ingredients can be divided into:
Among these, Vitamins and Omega-3, in the form of soft gel/pills, are the most purchased ingredients.
The bone and joint health ingredients find applications in:
The end-users of bone and joint health ingredients are:
The regions includes in the bone and joint health ingredients market are North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
People are getting busier and leading a hectic lifestyle, which makes maintaining a proper diet plan challenging, leading to an unhealthy lifestyle, which can significantly aid the market development as including some supplements can easily help compensate for the lack of nutrients. Most older people face some bone or joint issues; various pharmaceuticals are adopting health ingredients to treat different deficiency-related diseases. Healthcare officials are spreading awareness through various means, making people more attentive to their health.
The emerging countries are increasingly adopting these supplements as they become more aware of the benefits, and the market will have a promising growth due to the huge ageing population and the increasing spending power for healthcare. The governments of the two most populated countries, India and China, are investing heavily in the healthcare sector for research and development and new product launches which are most cost-effective so that more people can afford them, further propelling the market growth.
The report gives a detailed analysis of the following key players in the global bone and joint health ingredient market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The EMR report is carefully curated to provide detailed industry insights on the market based on Porter's five forces model, along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2016-2022 |
Forecast Period | 2023-2031 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Form |
|
Breakup by Type |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Bone and Joint Health Ingredients Market Overview
3.1 Global Bone and Joint Health Ingredients Market Historical Value (2016-2022)
3.2 Global Bone and Joint Health Ingredients Market Forecast Value (2023-2031)
4 Global Bone and Joint Health Ingredients Market Landscape
4.1 Global Bone and Joint Health Ingredients Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Bone and Joint Health Ingredients Product Landscape
4.2.1 Analysis by Form
4.2.2 Analysis by Type
4.2.3 Analysis by Application
4.2.4 Analysis by End User
5 Global Bone and Joint Health Ingredients Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Bone and Joint Health Ingredients Market Segmentation
6.1 Global Bone and Joint Health Ingredients Market by Form
6.1.1 Market Overview
6.1.2 Tablet Capsules
6.1.3 Soft Gel/Pills
6.1.4 Powder
6.1.5 Liquid
6.2 Global Bone and Joint Health Ingredients Market by Type
6.2.1 Market Overview
6.2.2 Vitamins
6.2.3 Calcium
6.2.4 Collagen
6.2.5 Glucosamine
6.2.6 Magnesium
6.2.7 Others
6.3 Global Bone and Joint Health Ingredients Market by Application
6.3.1 Market Overview
6.3.2 Dietary Supplement
6.3.3 Functional Foods and Beverages
6.3.4 Others
6.4 Global Bone and Joint Health Ingredients Market by End User
6.4.1 Market Overview
6.4.2 Men
6.4.3 Women
6.4.4 Senior Citizen
6.4.5 Others
6.5 Global Bone and Joint Health Ingredients Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Bone and Joint Health Ingredients Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Bone and Joint Health Ingredients Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Bone and Joint Health Ingredients Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Bone and Joint Health Ingredients Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Bone and Joint Health Ingredients Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Bayer AG
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Amway
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Procter & Gamble
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Innophos Holdings, Inc.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Glanbia Plc
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Vitawin
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Arazo Nutrition
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Simply Supplements
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Life Extension
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Now Foods
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Rousselot BV
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Waitaki Biosciences a division of PharmaZen Ltd.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Bioiberica S.A.U.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Bone and Joint Health Ingredients Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of USD 205.9 billion in 2022, driven by the rapidly expanding healthcare sector across the globe.
The market is expected to grow at a CAGR of 5.5% during the forecast period of 2023-2031 to reach a value of USD 333.4 billion by 2031.
The market is driven by the rising health awareness, progressively ageing population, and the increasing amount spent on healthcare products.
The rising awareness about the importance of fitness and health awareness is a key industry trend aiding the market growth.
The major regions in the industry are North America, Latin America, the Middle East, Africa, Europe, and the Asia Pacific, with Asia Pacific being the leading and fastest-growing market region.
The forms of the product can be divided into soft gel/pills, powder, and liquid.
The types of health ingredients include vitamins, calcium, collagen, glucosamine, omega 3, and magnesium, among others.
The dominant types in the industry are Vitamin and Omega-3.
The various applications of the health ingredients include dietary supplements and functional foods and beverages, among others.
The end-users of bone and joint health ingredients include men, women, and senior citizens, among others.
The major industry players driving the market are Rousselot BV, Waitaki Biosciences, a division of PharmaZen Ltd., Bioiberica S.A.U, Innophos Holdings, Inc., and Glanbia Plc, among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.